A single-center pediatric case series reports the use of systemic bevacizumab for treating juvenile recurrent respiratory papillomatosis. This study contributes to the understanding of treatment options for this rare condition.
juvenile recurrent respiratory papillomatosis treated with systemic bevacizumab a single center pediatric case series
Original title: “Juvenile recurrent respiratory papillomatosis treated with systemic bevacizumab: A single-center pediatric case series.”